JOURNAL ARTICLE
抗腫瘍性抗生物質FR901464の全合成(A・有機化学)
Year: 2001 Journal: ファルマシア Vol: 37 (7)Pages: 650-651
Abstract
Sacituzumab govitecan may present a new treatment option for recurrent USC patients harboring Trop-2+ tumors resistant to chemotherapy. Clinical trials with sacituzumab govitecan are warranted.
Keywords:
Computer science
Metrics
0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
0
Refs
Citation Normalized Percentile
Is in top 1%
Is in top 10%
Topics
Related Documents
JOURNAL ARTICLE
エンジイン系抗腫瘍抗生物質の生合成メカニズムに迫る(B・生薬・天然物化学)
Journal: ファルマシア Year: 2008 Vol: 44 (12)Pages: 1205-1206
JOURNAL ARTICLE
2 抗腫瘍性抗生物質echinomycinの酵素的全合成(口頭発表の部)
賢二 渡辺欣哉 堀田P Praseuth Alex健人 纐纈章 右田博毅 大栗N Boddy ChristopherC C Wang Clay英秋 及川
Journal: Medical Entomology and Zoology Year: 2005 Vol: 47 (47)Pages: 7-12
JOURNAL ARTICLE
P-41 抗腫瘍活性物質Curacin Aの全合成(ポスター発表の部)
Journal: Medical Entomology and Zoology Year: 1995 Vol: 37 (37)Pages: 511-516
JOURNAL ARTICLE
4 抗腫瘍性物質カズサマイシンの全合成研究(口頭発表の部)
Journal: Medical Entomology and Zoology Year: 2002 Pages: 19-24